7th efccna congress 2017 6 efccna congress 2015 horizons of critical care nursing in europe ......

6th EfCCNa CONGRESS 2015

Expanding Horizons of Critical Care Nursing in Europe

Valencia, Spain ● 29 - 31 January 2015

FINAL PROGRAMME

www.efccna.org

With support from the Sociedad Española de Enfermería Intensiva y Unidades Coronarias

7th EfCCNa Congress 2017

'Working together - Achieving more'

15-18 February 2017 | Belfast | Northern Ireland

FINAL PROGRAMME

www.efccna.org

Dece

mbe

r 201

6 D

EX50

65

Dexdor 100 micrograms per ml concentrate for solution for infusion (dexmedetomidine) Prescribing Information Indication: Sedation of adult ICU patients requiring sedation level not deeper than arousal in response to verbal stimulation (RASS 0 to -3). Dosage and administration: Hospital use only, by healthcare professionals skilled in management of patients requiring intensive care. Administer only as diluted intravenous infusion using controlled infusion device. Dexmedetomidine is very potent and the infusion rate is given per hour. Switch patients already intubated and sedated to dexmedetomidine with initial infusion rate of 0.7 micrograms/kg/h and adjust stepwise within range 0.2 to 1.4 micrograms/kg/h to achieve desired sedation level. Consider lower starting infusion rate for frail patients. After dose adjustment, new steady state sedation level may not be reached for up to one hour. Do not exceed maximum dose of 1.4 micrograms/kg/h. Switch patients failing to achieve an adequate level of sedation with maximum dose to an alternative sedative agent. Loading dose not recommended. Administer propofol or mida-zolam if needed until clinical effects of dexmedetomidine established. No experience in use of Dexdor for more than 14 days. Use for longer than this period should be regularly reassessed. Elderly: No dosage adjustment required. Renal impairment: No dosage adjustment required. Hepatic impairment: Caution advised; consider reduced dose. Paediatric population: Safety and efficacy have not been established. No recommendation can be made. Con-traindications: Hypersensitivity. Advanced heart block (grade 2 or 3) unless paced. Uncontrolled hypotension. Acute cerebrovascular conditions. Pregnancy. Warnings and precautions: Intended for use in intensive care setting, use in other environments not recommended. Continuous cardiac monitoring required. Monitor respiration in non-intubated patients. Do not use as induction agent for intubation or to provide sedation during muscle relaxant use. Dexmedetomidine reduces heart rate and blood pressure but at higher concentrations causes peripheral vasoconstriction and hypertension. Not suitable in patients who will not tolerate lack of deep sedation and easy rousability. Users should be ready to use alternative sedative for acute control of agitation or during procedures, especially during the first few hours of treatment. Caution with: pre-existing bradycardia; high physical fitness and slow resting heart rate; pre-existing hypotension, hypovolaemia, chronic hypotension or reduced functional reserve; severe ventricular dysfunction; the elderly; impaired peripheral autonomic activity (e.g. due to spinal cord injury); ischaemic heart disease or severe cerebrovascular disease; severe hepatic impairment; severe neurological disorders such as head injury and after neurosurgery. Reduce dose or discontinue if signs of myocardial or cerebral ischaemia. Additive effects may occur with other substances with sedative or cardiovascular actions. Some patients receiving dexmedetomidine have been observed to be arousable and alert when stimulated; this alone should not be considered as evidence of lack of efficacy. Do not use as sole treatment in status epilepticus. Consider possibility of withdrawal reaction if patient develops agitation and hypertension shortly after stopping dexmedetomidine. Not recommended in malignant hyperthermia-sensitive individuals. Discontinue treatment in event of sustained unexplained fever. Undesirable effects: Very common (>1/10): Bradycardia, hypotension, hypertension. Common (1>100 to <1/10): Hyperglycaemia, hypoglycaemia, agitation, myocardial ischaemia or infarction, tachycardia, respiratory depression, nausea, vomiting, dry mouth, withdrawal syndrome, hyperthermia. Uncommon (1>1,000 to <1/100): Metabolic acidosis, hypoalbuminaemia, hallucination, atrioventricular block first degree, cardiac output decreased, dyspnoea, apnoea, abdominal distension, drug ineffective, thirst. See SPC for further details. Legal category: POM. Presentations, basic NHS costs and marketing authorization numbers: Dexdor 2 ml ampoule x 5, £78.30, EU/1/11/718/001; Dexdor 4 ml vial x 4, £125.28, EU/1/11/718/004; Dexdor 10ml vial x 4, £313.20, EU/1/11/718/006. Distributed by: Orion Pharma (UK) Ltd. Oaklea Court, 22 Park Street, Newbury, Berkshire, RG14 1EA, UK. Full prescribing information is available on request. Dexdor is a registered trademark. Date of Prescribing Information: September 2016.

Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard. Adverse events should also be reported to Orion Pharma (UK) Ltd on 01635 520300.

1 Riker RR et al. JAMA. 2009; 301(5): 489-99. 2 Jakob SM et al. JAMA. 2012; 307(11): 1151-60

Calm Cooperative Patient

dexmedetomidine

Improving patient management and outcomes

dexdor® to• achieve a calm and cooperative patient1, 2

• enhance patient communication1, 2 • facilitate extubation1, 2

TABLE OF CONTENTS

WELCOME

2

COMMITTEES

3

ACKNOWLEDGEMENTS - SPONSORS

4

VENUE

8

REGISTRATION, NAME BADGES AND TICKETS

8

GENERAL INFORMATION

8

SOCIAL PROGRAMME

9

FLOOR PLAN EXHIBITION AND POSTER AREA

10

LIST OF EXHIBITORS

11

POSTERS – EfCCNa BEST POSTER AWARD

12

KEYNOTE SPEAKERS

13

PROGRAMME

THURSDAY 16 FEBRUARY 15 Programme at a glance 15 Full programme

16

FRIDAY 17 FEBRUARY 23 Programme at a glance 23 Full programme

24

SATURDAY 18 FEBRUARY 29 Programme at a glance 29 Full programme 30

POSTER PRESENTATIONS

33

© Copyright EfCCNa www.EfCCNa.org Disclaimer EfCCNa and Global Conference Support, its Board members, officers, agents and employees (hereafter referred to as: the organisers) accept no liability for personal injuries or loss, of any nature whatsoever, or for loss or damage to property either during or as a result of the 7th EfCCNa Congress. Delegates have been advised to arrange adequate travel, health, and other insurance before they leave their home country. Participation is completely at the participant’s own risk. The organisers will not be liable and will not compensate for any damage incurred to participants or the Conference Centre during the meeting. The organisers are hereby released from all claims.

2

WELCOME

Dear Delegates, As EfCCNa President and Chair of the Scientific Committee – and as a native of Belfast, Northern Ireland (NI), I am very much delighted to welcome delegates from all over the world to the 7th European federation of Critical Care Nursing associations (EfCCNa) Congress here in Belfast, NI. I know that you will find an all-round inspiring environment in both the Congress and its excellent location. This exciting Congress is dedicated to Working Together Achieving More. In the Congress we have put together emphasis on international developments to address key challenges that impact on critical care within Europe. Professor Paul Fulbrook (Australia) opens the congress by setting the scene on ‘What’s happening in the world of critical care’. This is followed by Professors Leanne Aitken (London) and Stijn Blot (Belgium) discussing two major global challenges in critical care – patients’ long term recovery and antibiotic stewardship. The penultimate global session focuses on hot topics affecting critical care reported by the critical care nursing leads from the societies of EfCCNa, ESICM, WFCCN and the Society of Critical Care Medicine (SCCM). The Congress programme has been designed to provide you with many high quality clinical, educational, and research talks and posters that will have wide appeal and will no doubt stimulate intellectual debate. I am pleased to announce that we have accepted 188 abstracts from colleagues representing 26 countries. I am delighted to say that this is due to the hard work of the Scientific Committee in not only reviewing the abstracts, but raising the standard of the quality of papers being presented. We have put together 14 themed parallel sessions; six interactive workshops; four themed symposia; two master classes in patient safety and research methods; and a sponsored plenary session on Pain, Sedation and Delirium (ORION). The EfCCNa Congress is where you and your colleagues will come together to share cutting edge ideas that can make a difference to patient care. The large variety of clinical and scientific contributions at the Congress will assure that all delegates will find new and exciting ideas to inspire them. You will have the opportunity to learn from others through the presentations, poster sessions, master classes, workshops, symposia and panel discussions. The exhibitors will also provide delegates with the opportunity to learn about the latest products and services in health information and information technology. To all the Organising and Scientific Committee members, I give my personal thanks and congratulations. I hope that you will enjoy EfCCNa’s exciting scientific programme alongside the experience of Belfast and NI’s unique location. I am confident that you will return from the Congress inspired by colleagues from around the world and that you will have made new friends and research contacts that will support you in your essential work.

Bronagh Blackwood EfCCNa President Chair Scientific Committee

3

COMMITTEES

We express our gratitude for the expertise and efforts of the following groups of organisers:

Organising Committee Chair: Eva Barkestad, Sweden Elin Steffenak, Norway Mette Ring, Denmark Rósa Thorsteinsdóttir, Iceland Daniel Benlahouès, France Lerma Hernandes, Belgium Adriano Friganovic, Croatia Colette Ram, the Netherlands Una St Ledger, Northern Ireland Leona Bannon, Ireland Christine Sheenan, Ireland

Scientific Committee Chair: Bronagh Blackwood, Northern Ireland Co-Chair: Frederique Paulus, the Netherlands Evanthia Georgiou, Cyprus Yvonne Tume, England Irene Harth, Germany Tom Andrews, Ireland Julie Benbenishty, Israel Enrico Lumini, Italy Hege Haughdahl, Norway Claire Kydonaki, Scotland Eva Akerman, Sweden Alicia San Jose, Spain Pilar Delgado-Hito, Spain Jenny McGaughey, N. Ireland Wioletta Medrzycka-Dabrowska, Poland Aysel Basir, Turkey

Executive Committee Bronagh Blackwood, Northern Ireland Eva Barkestad, Sweden Elin Steffenak, Norway Rosa Thorsteinsdóttir, Iceland Ronald Ligterink, The Netherlands

Host

European federation of Critical Care Nursing Associations (EfCCNa)

www.EfCCNa.org

Congress Organisers

Global Conference Support Babette Schmidt and Ronald Ligterink Amsterdam, the Netherlands E-mail: [email protected] www.globalconferencesupport.com

4

ACKNOWLEDGEMENTS - SPONSORS

EfCCNa and the Committees express their warm thanks to the financial contributors below for their support. We encourage all delegates to visit the Exhibition and learn more about the products and services. PLATINUM SPONSOR

Stand P1 www.orionpharma.com Orion is a globally operating Finnish pharmaceuticals company – a builder of well-being already since 1917. Orion develops, manufactures and markets human and veterinary pharmaceuticals, active pharmaceutical ingredients and diagnostic tests. It is continuously developing new drugs and treatment methods. Orion Pharma’s critical care product portfolio includes two own proprietary molecules, the alpha2-agonist dexmedetomidine (dexdor®) for light sedation of patients in intensive care units and levosimendan (Simdax®) for acutely decompensated heart failure. Orion's customers are mainly healthcare service providers and professionals such as specialist and general practitioners, veterinarians, pharmacies, hospitals, healthcare centres, clinics and laboratories. Consumers with pets are another important customer group. Orion's main market is Finland, where it is the clear market leader. Orion’s products are marketed in over a hundred countries, and the Group's own human pharmaceuticals sales organisation covers almost all key European markets. In other markets Orion’s products are sold by several collaboration partners. All of Orion's manufacturing plants and most of its R&D operations are in Finland. Orion’s headquarters are in Espoo, Finland. GOLD SPONSORS

Stand G1 www.armstrongmedical.net Armstrong Medical Ltd. based on the beautiful Northern Ireland Causeway Coast was established in 1984 and has grown considerably to become a worldwide manufacturer of innovative respiratory disposables for Neonatal Care, Anaesthesia and Respiratory Care. Armstrong Medical’s Respiratory Care range supports the patient and care giver as they transition between respiratory therapies. Flowkit Our customised Flowkit range offers a “ready-to-go” solution to minimise set up time, aid transition between respiratory therapies and reduce waste, inventory costs and storage requirements. AquaVENT® AquaVENT® heated breathing systems combine technological advances in thermal conductivity and breathing circuit construction to deliver optimal and controlled humidification. AquaVENT® heated breathing circuits contain BioCote® antimicrobial silver additive to limit the number of microbes on the surface of the breathing circuit, protecting it from microbial colonisation.

5

Armstrong Medical ltd (continued) FD140 The FD140 is a new generation flow driver for mask or helmet CPAP and high flow humidified oxygen therapy. The FD140 flow driver is significantly quieter than alternative high flow drivers benefiting patients, visitors and care providers. Universal Face Mask Since introducing Armstrong Medical’s mask, we have seen a significant increase in patient compliance and success.

Stand G3 www.aerogen.com Aerogen is the world’s leading medical device company specialising in the design, manufacture and commercialisation of aerosol drug delivery systems. Aerogen’s patented vibrating mesh technology turns liquid medication into a fine particle mist, gently and effectively delivering drugs to the lungs of critically ill patients of all ages. Aerogen’s innovative products, such as the Aerogen® Solo and Aerogen® Ultra, significantly improve aerosol drug delivery resulting in better patient care throughout the Hospital. Founded in Galway, Ireland in 1997, Aerogen has grown to become the global leader in high performance aerosol drug delivery and has partnered its technology with the leading mechanical ventilation companies. Aerogen technology is used by millions of patients and caregivers in over 75 countries worldwide.

Stand G2 www.sidhil.com Sidhil is a British healthcare company providing high quality solutions focused on the changing requirements of acute, community, nursing home and GP environments. The only remaining volume manufacturer of hospital beds in the UK, Sidhil offers a product range including electrically operated profiling beds, dynamic and static surfaces, overbed tables, trolleys, couches, plinths and treatment chairs, aids for daily living and a selection of specially engineered bariatric products. With service centres located across the UK, Sidhil provides professional and reliable maintenance facilities, backed up by fast availability of parts. Products are available for sale and lease, with solutions designed around individual customer requirements.

6

SILVER SPONSORS

Stand S5 www.beagleorthopaedic.com Beagle Orthopaedic is a Lancashire based company with an excellent reputation for both quality products and Customer Service. As a company we believe strongly in the clinical efficiency of all our products and providing educational support forms such a large part of our company ethos and brand promise. We believe that training and education is key in attaining increased patient outcomes and work closely with all clinicians to ensure that his is instilled within the hospital.

Stand S9 www.dalemed.net Dale Medical is a US based manufacturer of speciality products within the medical device industry. Their critical care products are designed with a focus to help the healing process, improve patient comfort, safety and satisfaction with an emphasis to save nursing time. Dale Medical's quality products are distributed in every European country.

Stand S8 www.edwards.com Since the first successful heart valve replacement with the Starr-Edwards Silastic Ball Valve more than 50 years ago, Edwards Lifesciences has been dedicated to providing innovative solutions for people fighting advanced cardiovascular disease, the world’s leading cause of death and disability. Edwards is the global leader in the science of heart valves and hemodynamic monitoring. Driven by a passion to help patients, the company and its 7000 employees partner with clinicians to develop innovative technologies in the areas of structural heart disease and critical care monitoring that enable them to save and enhance lives.

Stand S2 www.elcam.co.il Patient and caregiver safety is our passion. We strive to maximize safety through aggregation of marginal gains, because safety is in the details. We are leading the effort to improve safety in medical fluid management in acute settings, such as pressure monitoring, I.V therapy / drug delivery and dialysis. Amongst our specialty products is the Marvelous Stopcock, specially designed to increase safety and save precious time for the critical care nurse.

7

Stand S7 www.hameln.co.uk hameln is a leading supplier of high quality generic medicines, ranging from water for injections to sedatives, anaesthetics, analgesics and antidotes. We have recently developed products with standardised drug infusion concentrations for use in critical care, including an increasing number of Ready-to-Use solutions, focussed on reducing the potential for medication errors, such as Fentanyl 50 mcg/ml 50 ml vial. Today, our products are available in more than 40 countries throughout the world.

Stand S1 www.intersurgical.co.uk Intersurgical manufactures a complete range of respiratory care products including breathing systems, active humidification systems & devices, a full oral care programme, breathing filters and HMEFs a range of oxygen & aerosol therapy options and a range of NIV and CPAP products including the StarMed helmet range. Choose Intersurgical for quality, innovation and choice.

Stand S6 www.its-novo.com Novo Klinik-Service GmbH develops, produces and sells innovative medical devices and solutions for the intensive care, anaesthesia and care sectors. For more than 25 years, our name has been synonymous with safe, comfortable, user-friendly, economical and high quality products - Made in Germany. P3 is working as our exclusive partner in the UK.

Stand S3

www.getinge.com Getinge Group is a leading global provider of innovative solutions for operating rooms, intensive-care units, hospital wards, sterilization departments, elderly care and for life science companies and institutions. With a genuine passion for life we build quality and safety into every system. Our unique value proposition mirrors the continuum of care, enhancing efficiency throughout the clinical pathway. Based on our first-hand experience and close partnerships, we are able to exceed expectations from customers – improving the every-day life for people, today and tomorrow.

8

VENUE

Belfast Waterfront 2 Lanyon Place Belfast County Antrim BT1 3WH website: waterfront.co.uk REGISTRATION, NAME BADGES AND TICKETS

Registration Desk - Opening hours Wednesday 15 February 16.30 - 18.30 Pre-registration Thursday 16 February 08.00 - 17.30 Friday 17 February 08.45 - 17.00 Saturday 18 February 09.00 - 12.30 Name badges and tickets For security purposes, delegates and exhibitors must wear their name badge at all times. The EfCCNa Committee and Council members can be identified by their badge with a yellow bar and a blue lanyard. Access to the scientific sessions and the complimentary coffee, tea and lunch will only be provided to badge holders only. Tickets for the Congress Party on Friday 17 February have been issued to delegates who have booked for this event. Please present your ticket(s) at this event. There may be some tickets left, please ask at the Registration Desk. GENERAL INFORMATION

Abstracts The abstracts are published on the Congress website as a downloadable PDF file. Due to environmental reasons the abstracts will not be made available in print. Certificate of attendance A certificate of attendance stating the number of contact hours will be sent to you by e-mail within 2 weeks after the Congress. The Congress will not be offering accreditation credits. Cloakroom The cloakroom is located at the Reception Desk of the Conference Centre on the ground floor. Opening hours:

Thursday 16 February 08.00 - 18.00 Friday 17 February 08.45 - 17.30 Saturday 18 February 09.00 - 13.00

Please make sure to collect your coat before closure time. The cloak room is not guarded. The organisers cannot accept any liability for loss or damage to property left unattended. Congress language The official congress language is English. Dress code The dress code during the entire meeting is “smart casual”. Internet Wireless internet is available at no charge throughout the entire Conference Centre. Open your browser and select ‘waterfront’. Then enter your email address. No password is needed.

9

Insurance Delegates and exhibitors are required to have appropriate health, travel and private liability insurances. The organisers will not be responsible for any medical expenses incurred by participants and will not accept any liability for personal injuries sustained, or for loss or damage to property belonging to participants or to the Conference Centre. Messages Messages for delegates should be handed in at the Registration Desk. Notification of messages will be displayed on the message board located next to the Registration Desk. Please check the board daily and pick up your messages – they may be urgent. Mobile telephones / cameras Mobile phones must be switched off when delegates are in the meeting rooms. The use of cameras are not permitted during oral presentations. Programme changes The organisers reserve the right to adjust or change the programme as necessary. Smoking policy Smoking is not permitted at the conference facilities. Smoking is not allowed in all enclosed spaces in Belfast including offices, restaurants and pubs.

SOCIAL PROGRAMME

WELCOME RECEPTION Date: Wednesday 15 February Location: Belfast City Hall Time: 18.30 - 20.00 hrs. Cost: Free of charge for registered delegates and their accompanying persons.

The Welcome Reception will take place at the Belfast City Hall. All participants are invited to collect their badge and other conference materials at the Conference Center prior the Welcome Reception. The address is mentioned on your voucher (max. 10 walking distance from the Conference Centre). We thank Belfast City Council for their kind generosity for the use of City Hall and the provision of hospitality. CONGRESS DINNER & DANCE Date: Friday 17 February Location: Titanic Belfast Time: 20.00 - 23.30 hrs. Dress: Smart casual Cost: € 55 including drinks during dinner. Pre-registration is required. Please do not forget to take your voucher with you! There may be some tickets left, please contact the Registration Desk before Thursday 16 February 11.00 hrs. Transportation: On your own. The address is mentioned on your voucher.

The Congress Dinner Party will take place at the Titanic Belfast, the world’s largest Titanic Visitor Experience. It is located at the heart of the waterfront Titanic Quarter, the historic site of where the RMS Titanic was designed and built. You will dine in the Titanic Suite, a breathtaking room inspired by the Titanic’s interiors, including a replica of the Titanic Grand Staircase. Bring your dancing shoes and dance the night away after dinner!

10

FLOOR PLAN

P1

G1

Foyer / Lobby

Poster boards S5 S6 S7

Buffet

Buffet

Standing tables

1B1C

1D

Standing tables

S8

EXHIBITION AND POSTERSHall 1B-1C-1DLevel 1

T1

S9

11

LIST OF EXHIBITORS P - Platinum Sponsor S - Silver Sponsors G - Gold Sponsors T - Table top displays

Alphabetical order Numeric order Aerogen G3 P1 Orion Pharma Armstrong Medical G1 G1 Armstrong Medical Beagle Orthopaedic Limited S5 G2 Sidhil Ltd Belfast ICUsteps T2 G3 Aerogen Dale Medical S9 S1 Intersurgical Edwards Lifesciences S8 S2 Elcam Medical EfCCNa T4 S3 Getinge Group - Maquet Elcam Medical S2 S5 Beagle Orthopaedic Limited ESPNIC T3 S6 Novo Klinik-Service GmbH Getinge Group - Maquet S3 S7 hameln pharmaceuticals hameln pharmaceuticals S7 S8 Edwards Lifesciences Intersurgical S1 S9 Dale Medical Novo Klinik-Service GmbH S6 T1 Queens University Belfast Orion Pharma P1 T2 Belfast ICUsteps Queens University Belfast T1 T3 ESPNIC Sidhil Ltd G2 T4 EfCCNa

Armstrong ½ page advertisement ZWART-WIT

12

POSTERS For an overview of the posters and poster board numbers, please see page 33. All posters will be on display from Thursday 16 February 10.15 hrs. until Saturday 18 February 11.00 hrs. Poster discussions Presenters will be by their posters for discussion • during the morning coffee breaks on Thursday, Friday and Saturday, and • the second half of the lunch break on Thursday and Friday EfCCNa BEST ABSTRACT & POSTER AWARDS Three best abstract awards will be allocated by the Scientific Committee prior to the Congress. These prizes will cover free registration for the 2019 Congress (worth approx. EUR 450). The best poster award will be judged by the congress delegates and will provide up to EUR 500 to cover travel or accommodation costs associated with the Belfast Congress. The winners will be announced at the Closing Session on Saturday 18 February.

Aegen ½ A4 Advertisement ZWART-WIT

PM360

Aerogen’s pioneering aerosol drug delivery has proven its ability to enhance patient flow in the Emergency Department. Compared to standard small volume nebulisers, Aerogen Ultra demonstrated:

• 32% reduction in admissions1

• 37 minute reduction in median length of stay1

• 75% lower drug use.1

aerogen.comDiscover Better

BETTER IS FASTER

1 Dunne R et al. Aerosol dose matters in the Emergency Department: A comparison of impact of bronchodilator administration with two nebulizer systems. Poster at the American Association for Respiratory Care. 2016

5540 AER PM360 Better is Faster Global Conference ad F.indd 1 25/01/2017 14:30

13

KEYNOTE SPEAKERS

His current role is a joint appointment as Professor of Nursing with the Australian Catholic University and Nursing Director Research at The Prince Charles Hospital in Brisbane (a 630-bed tertiary hospital specialising in cardiothoracic care), where he leads the Nursing Research and Practice Development Centre. Within the critical care context, he has published widely, has spoken at many international and national conferences, and is currently involved with several research projects in intensive care and emergency care. Paul is a past President of the Australian College of Critical Care Nurses (ACCCN), and has served on its National Board for several years. He helped to establish the World Federation of Critical Care Nurses (WFCCN) and is Emeritus Editor of its journal Connect: The World of Critical Care Nursing. He was the lead convenor and co-chair of the Scientific Committee for the 2016 WFCCN/ACCCN joint international conference, which was held in Brisbane, Australia. Paul’s contribution to critical care nursing has been recognised formally via fellowships from the British Association of Critical Care Nurses and the European Federation of Critical Care Nursing Associations, and as a WFCCN Honorary Ambassador. He is the current President of the WFCCN.

Dr. Blot (co-)authored over 250 international publications, adding to a H-index of 46; he also (co-) authored 29 chapters in books and was editor of 11 books. He is unique through a profound and varied background combining nursing and midwifery, nursing sciences, a special degree in emergency and intensive care, a post-academic teaching degree, and a PhD in medical sciences. This exceptional career track allows bridging distinct disciplines and interpreting clinical data in an exclusive way. He succeeded to consolidate a solid reputation in intensive care research and established a firm international network of collaborators encompassing a broad variety of disciplines. His work is recognized with several national and international awards, among which the Interscience Conference on Antimicrobial Agents and Chemotherapy 2005 and European Society of Clinical Microbiology and Infectious Diseases 2007 young investigator award, and the European Critical Care Research Network ESICM Patient Safety Award 2008. In 2015 Dr. Blot was inducted in the International Nurse Researcher Hall of Fame of the Sigma Theta Tau International Honor Society of Nursing.

Professor Paul Fulbrook Professor of Nursing with the Australian Catholic University and Nursing Director of Research at The Prince Charles Hospital in Brisbane, Australia; President of the World Federation of Critical Care Nurses (WFCCN). Paul has worked in critical care nursing since 1986 in various clinical, educational, research, and professional roles. He qualified as an intensive care nurse in the UK and emigrated to Australia in late 2004.

Professor Stijn Bot Professor at Ghent University Belgium, Faculty of Medicine & Health Sciences; research officer at the ESICM.

Dr. Blot is full professor at Ghent University and honorary professor at The University of Queensland. He has a main focus on prevention and clinical epidemiology of healthcare-associated complications in critically ill patients such as life-threatening infections and pressure ulcers.

14

Professor Aitken holds visiting appointments with Griffith University and Princess Alexandra Hospital, as well as the University of Edinburgh and the University of Dundee in the UK. She is a Fellow of both the American Academy of Nursing and the Australian College of Nursing as well as a Life Member and Fellow of the Australian College of Critical Care Nurses. She is also a Fulbright Alumnus after receiving a Fulbright Senior Scholarship to undertake research examining recovery after trauma at the University of Pennsylvania, Philadelphia. Professor Aitken has published more than 100 original publications in peer reviewed journals and edits ACCCN’s Critical Care Nursing textbook.

Notes:

Professor Leanne Aitken

Professor of Nursing, City University London, London, UK. Professor Leanne Aitken is Professor of Nursing at City, University of London. In this role she is responsible for leading research and scholarship in acute and critical care nursing as well as implementing her own programme of research that focuses on recovery after critical illness and injury and a range of clinical practice issues within critical care. Other responsibilities include teaching and supervision of research students.

15

THURSDAY 16 FEBRUARY - PROGRAMME AT A GLANCE

PLENARY HALL

09.00-10.15

Plenary Session 1 Opening Ceremony & Keynote Lecture

Welcome addresses Keynote Lecture: Professor Paul Fulbrook: What’s happening in the world of critical care

nursing?

10.15-11.00 Coffee break - Exhibition - Posters

PLENARY HALL ROOM 3 ROOM 2 ROOM 1

11.00-12.30

Oral Presentations 1

Managing Pain/Sleep

Oral Presentations 2 Family-centred care

Symposium 1

Nursing Activities Score

Workshop 1

SCREAM max. 50 pax*

12.30-13.30 Lunch break - Exhibition - Posters

PLENARY HALL

13.30-14.00 ORION Industrial Partner Presentation Daniel Conway: Evidence Based Critical Care for Pain Agitation and Delirium


14.00-15.30


Pain, agitation & Delirium

Oral Presentations 4 Palliation and end of

life


Organisation

Symposium 2

ESPNIC – Psychological care of

the Child and family/siblings in the

ICU

15.30-16.00 Coffee break - Exhibition – Posters


16.00-17.30 Oral Presentations 6

Breathing

Oral Presentations 7 Critical Care Education

Symposium 3 Sex and Stress in the

ICU

Masterclass 1 Patient Safety

To err is human

* Please collect an entrance ticket at the Registration Desk. First come, first served!

16

THURSDAY 16 FEBRUARY - FULL PROGRAMME 09.00-10.15 PLENARY 1 OPENING CEREMONY & KEYNOTE LECTURE

PLENARY HALL

09.00-09.15 Words of Welcome − Dr Bronagh Blackwood, President of EfCCNa and Chair Scientific

Committee − Charlotte McArdle, Chief Nursing Officer, Department of Health

Northern Ireland − Eva Barkestad, Chair Organising Committee

09.15-10.15 PLE-1 Keynote lecture: What’s happening in the world of critical care nursing? Paul Fulbrook, Australia

10.15-11.00 BREAK - POSTERS - EXHIBITION 11.00-12.30 ORAL

PRESENTATIONS 1 MANAGING PAIN/SLEEP

PLENARY HALL

11.00-11.15 OP1-01 Validation of the Danish version of the Critical-Care Pain Observation Tool Janne Bruun Frandsen, Denmark

11.15-11.30 OP1-02 Sleep Determinants among Patients in an Intensive Care Unit Wioletta Medrzycka-Dabrowska, Poland

11.30-11.45 OP1-03 'Analgosedation in intensive care' - patients' experiences one week and three months after discharge Helene Berntzen, Norway

11.45-12.00 OP1-04 The critical care nurses' perspective of pain and their self-reported practices of pain management toward nonverbal clients Jie Chen, China

12.00-12.15 OP1-05 The relationship between pain and physiological symptoms in ICU survivors 3 and 12 months after ICU discharge Anne Kathrine Langerud, Norway

12.15-12.30 OP1-06 Sleep quality of non-intubated patients in an ICU Marita Ritmala-Castren, Finland

Notes:

17

Thursday 16 February - continued

11.00-12.30 ORAL PRESENTATIONS 2

FAMILY-CENTRED CARE

ROOM 3

11.00-11.15 OP2-01 Critical care nurses and relatives of elderly patients in intensive care unit - Ambivalent interaction Abder Rahim Akroute, Norway

11.15-11.30 OP2-02 Health Promoting Conversation for Families - with a critical ill family member Gunilla Hollman Frisman, Sweden

11.30-11.45 OP2-03 Impact of a booklet done for children visiting their relatives in the icu on the satisfaction of accompanying adults Carole Haubertin, France

11.45-12.00 OP2-04 Supporting children and teenagers as relatives in the Intensive Care Unit Heidi Bild Granby, Denmark

12.00-12.15 OP2-05 Families' experiences of quality of care for ICU patients and their families: the euroQ2 project Hanne Irene Jensen, Denmark

12.15-12.30 OP2-06 Children as relatives of critically ill patients in ICUs Birte Baktoft, Denmark

11.00-12.30 SYMPOSIUM 1 NURSING ACTIVITIES SCORE (NAS) AND THE STATE OF

ART: PAST, PRESENT AND FUTURE

ROOM 2

Chairs: Clémence Dallaire, Canada and Siv K. Stafseth, Norway

SYM1-01 Nursing workload in the intensive care units: an international multicentre study using the Nursing Activities Score (NAS) Katia Grillo Padilha, Brazil

SYM1-02 The use of the Nursing Activities Score in clinical settings: an integrative review Maria Cecilia Gallani, Canada

SYM1-03 Association of Nursing Activities Score and nurse staffing costs in Norway Siv K Stafseth, Norway

SYM1-04 Assessment of costs of nursing care in Intensive Care Units Elaine Machado de Oliveira, Brazil

SYM1-05 Rethinking instruments in light of Intensive Care Nursing advancements: Findings from Italian exercise on Nursing Activities Score face and content re-validity study Alvisa Palese, Italy

SYM1-06 Adequacy of nursing staff and adverse outcomes in an International Multicenter Research Project: contribution of Nursing Activities Score (NAS) Katia Grillo Padilha, Brazil

Thursday 16 February - continued 11.00-12.30 ORAL

PRESENTATIONS 2 FAMILY-CENTRED CARE

ROOM 3

11.00-11.15 OP2-01 Critical care nurses and relatives of elderly patients in intensive care unit - Ambivalent interaction Abder Rahim Akroute, Norway

11.15-11.30 OP2-02 Health Promoting Conversation for Families - with a critical ill family member Gunilla Hollman Frisman, Sweden

11.30-11.45 OP2-03 Impact of a booklet done for children visiting their relatives in the icu on the satisfaction of accompanying adults Carole Haubertin, France

11.45-12.00 OP2-04 Supporting children and teenagers as relatives in the Intensive Care Unit Heidi Bild Granby, Denmark

12.00-12.15 OP2-05 Families' experiences of quality of care for ICU patients and their families: the euroQ2 project Hanne Irene Jensen, Denmark

12.15-12.30 OP2-06 Children as relatives of critically ill patients in ICUs Birte Baktoft, Denmark

11.00-12.30 SYMPOSIUM 1 NURSING ACTIVITIES SCORE (NAS) AND THE STATE OF

ART: PAST, PRESENT AND FUTURE

ROOM 2

Chairs: Clémence Dallaire, Canada and Siv K. Stafseth, Norway

SYM1-01 Nursing workload in the intensive care units: an international multicentre study using the Nursing Activities Score (NAS) Katia Grillo Padilha, Brazil

SYM1-02 The use of the Nursing Activities Score in clinical settings: an integrative review Maria Cecilia Gallani, Canada

SYM1-03 Association of Nursing Activities Score and nurse staffing costs in Norway Siv K Stafseth, Norway

SYM1-04 Assessment of costs of nursing care in Intensive Care Units Elaine Machado de Oliveira, Brazil

SYM1-05 Rethinking instruments in light of Intensive Care Nursing advancements: Findings from Italian exercise on Nursing Activities Score face and content re-validity study Alvisa Palese, Italy

SYM1-06 Adequacy of nursing staff and adverse outcomes in an International Multicenter Research Project: contribution of Nursing Activities Score (NAS) Katia Grillo Padilha, Brazil

18


11.00-12.30 WORKSHOP 1 SCREAM: STANDARDISED CRITICAL CARE RESUSCITATION AND EMERGENCY AIRWAY MANAGEMENT

ROOM 1

Maximum number of participants: 50. Please collect an entrance ticket at the Registration Desk. First come, first served!

This workshop will be repeated on Friday.

Chair: Majella Dillon, Northern Ireland

Team: Gareth Morrison, Bill Hickland, Matt Jasztal, Karen Conn, Robert McMonagle, Catherine McFall, Blinnia Hughes and Christina McMahon

Can't Intubate Can't Oxygenate

A blocked tracheostomy tube

12.30-13.30 LUNCH BREAK - POSTERS - EXHIBITION 13.30-14.00 PLENARY SESSION ORION Industrial Partner Presentation

PLENARY HALL

13.30-14.00 Evidence Based Critical Care for Pain Agitation and Delirium (PAD) Daniel Conway, Consultant in Critical Care, Manchester Royal Infirmary Manchester Academic Health Science Centre, UK

14.00-15.30 ORAL

PRESENTATIONS 3 PAIN, AGITATION & DELIRIUM

PLENARY HALL

14.00-14.30 OP3-01 Putting Pain, Agitation & Pain (PAD) guidelines in to practice: Humane Care in Critical Care Donna Cummings, UK

14.30-14.45 OP3-02 Non-pharmacological management of delirium in critically ill patients Leona Bannon, Northern Ireland

14.45-15.00 OP3-03 Managing a study protocol of no-sedation in bustling ICUs,- twisting the study to fit the culture? Ranveig Lind, Norway

15.00-15.15 OP3-04 He survived thanks to a non-sedation protocol - Nurses' reflections about caring for critically ill, non-sedated and ventilated ICU-patients Inga Akeren, Norway

15.15-15.30 OP3-05 Analgo-sedation versus merely a systematic approach to pain treatment and sedation, - any significance for the ICU patient? Hilde Wøien, Norway

19



PALLIATION AND END OF LIFE ROOM 3

14.00-14.15 OP4-01 Starting palliative care for heart failure patients Mali Bartal, Israel

14.15-14.30 OP4-02 Critical Care Nurses' Perceptions of the Quality of Death in the Intensive Care Unit Sonya Sharaby, Israel

14.30-14.45 OP4-03 Perception of Quality palliative care and barriers to providing palliative care at end of life among Intensive Care Unit nurses Ferda Dekeyser Ganz, Israel

14.45-15.00 OP4-04 Moral distress in end-of-life care decisions in the intensive care unit Una St Ledger, United Kingdom

15.00-15.15 OP4-05 The experience of grief and death in intensive care Tamara Raquel Velasco Sanz, Spain

15.15-15.30 OP4-06 Maximising family consent for organ donation: The introduction of an aide to planning the family approach conversation Monica Hackett, Northern Ireland

14.00-15.30 ORAL

PRESENTATIONS 5 ORGANISATION

ROOM 2

14.00-14.15 OP5-01 From a ward leader perspective: Using protocols in ICU practice Bronagh Blackwood, Northern Ireland

14.15-14.30 OP5-02 Influence of construction and design of an Intensive Care Unit on perception and well-being of patients Meggy Peters, The Netherlands

14.30-14.45 OP5-03 Acceptance of a new electronic medical records system among the nursing staff in ICUs based on TAM2 Alexander Furmanov, Israel

14.45-15.00 OP5-04 The influence of a professional development intervention on critical care nurse intent to stay Sandra Goldsworthy, Canada

15.00-15.15 OP5-05 MSc nurses as professional development coordinators: an ingredient in quality, professional development and patient safety? Hilde-Irén Liland, Norway

15.15-15.30 OP5-06 Implementing a structured team briefing in changes of shifts Dana Arad, Israel

14.00-15.30 SYMPOSIUM 2 ESPNIC – PSYCHOLOGICAL CARE OF THE CHILD AND FAMILY/SIBLINGS IN THE ICU

Chair: Lyvonne Tume, UK

ROOM 1

SYM2-01

The child in the adult ICU setting: Is there special attention needed? Jos Latour, UK

SYM2-02

Children visiting their relatives in the adult ICU: how to manage this Gillian Colvill, UK

20

Thursday 16 February – continued

15.30-16.00 BREAK - POSTERS - EXHIBITION 16.00-17.30 ORAL

PRESENTATIONS 6 BREATHING

PLENARY HALL

16.00-16.15 OP6-01 Use of the Electrolarynx for Enabling Communication in the CHrOnically Critically Ill (EECCHO) study Louise Rose, Canada

16.15-16.30 OP6-02 Underestimation of Patient Breathlessness by Nurses and Physicians during a Spontaneous Breathing Trial Hege Selnes Haugdahl, Norway

16.30-16.45 OP6-03 The Breath of Life. Patients' Experiences of Breathing During and After Mechanical Ventilation Hege Selnes Haugdahl, Norway

16.45-17.00 OP6-04 Person-centred care in ICU during weaning from prolonged mechanical ventilation Carl-Johan Cederwall, Sweden

17.00-17.15 OP6-05 Newly founded Dutch national ICU weaning expertise center (NExCOB) introduces unique holistic weaning approach Joyce Janssen, The Netherlands

17.15-17.30 OP6-06 Descriptive study of a sample of self extubation patients Victor Gomez Simon, Spain


CRITICAL CARE EDUCATION

ROOM 3

16.00-16.15 OP7-01 Effects of a simulated resuscitation with a relative member present on the public's views of family witnessed resuscitation John Abarran, UK

16.15-16.30 OP7-02 Introducing Palliative Care into the ICU: Results of an Educational Intervention Freda Dekeyser Ganz, Israel

16.30-16.45 OP7-03 From novice nurse to young expert using simulation in house education Naela Hayek, Israel

16.45-17.00 OP7-04 Development and evaluation of a novel simulation based approach to sepsis education in undergraduate nursing Billiejoan Rice, United Kingdom

17.00-17.15 OP7-05 Standardized simulation-based acute and intensive care nursing curriculum to increase nursing students simulated resuscitation performance: a quasi-experimental study Jie Chen, China

17.15-17.30 OP7-06 Mentoring students in the critical care setting Ann-Charlotte Falk, Sweden



ROOM 3







17.30-17.45 OP7-07 Evaluation of the efccna icu competencies in the light of legal and educational frameworks, and advanced nursing developments in Germany Daniela Lehwaldt, Ireland

21

Thursday 16 February – continued

16.00-17.30 SYMPOSIUM 3 SEX AND STRESS IN THE ICU

Chair: Julie Benbenishty

ROOM 2

SYM3-01

SIRS & Sepsis: Differences in the inflammatory response Julie Benbenishty, Israel

SYM3-02

The Cardiovascular System of Men and Women Mali Bartal, Israel

SYM3-03 The response to stress: Does sex play a part? Freda DeKeyser Ganz, Israel

SYM3-04 Gender differences in long term ICU rehabilitation Yardena Drori, Israel

SYM3-05 Relationship between gynecology and cardiology: Updates on hormone replacement therapy and cardiac disease in post-menopausal women Ofra Ranaan, Israel

16.00-17.30 MASTERCLASS 1 PATIENT SAFETY - TO ERR IS HUMAN

ROOM 1

Clinical errors in the ICU: Why mistakes happen, and potential strategies to prevent them David Waters, UK & Sandra Goldsworthy, Canada

Notes:



ROOM 3







17.30-17.45 OP7-07 Evaluation of the efccna icu competencies in the light of legal and educational frameworks, and advanced nursing developments in Germany Daniela Lehwaldt, Ireland

22

Notes:

23

FRIDAY 17 FEBRUARY - PROGRAMME AT A GLANCE

PLENARY HALL

09.15-10.15 Plenary Session 2 Keynote Lecture

Professor Leanne Aitken: Long term psychological and cognitive recovery after critical illness



11.00-12.30

Parallel Session 8

Respiratory management of

critically ill patients sponsored by

Armstrong Medical

Oral Presentations 9 ICU Complex Care


ICU Nursing Workload

Masterclass 2

Research Methods

12.30-13.30 Lunch break - Exhibition - Posters


13.30-15.00


Infection Control


Perioperative Care

What’s new in

Clinical Research

Workshop 2

SCREAM max. 50 pax*



15.30-17.00


Mobilisation & Restraint


Psychological Care

Workshop 3

ESPNIC - Caring for a child in an adult ICU

max. 40 pax*

Workshop 4

Manual Hyperinflation sponsored by

Armstrong Medical Belfast

max. 30 pax*

20.00-23.30

Congress Party at Titanic Belfast

Pre-registration required. See page 9 for more information.

* Please collect an entrance ticket at the Registration Desk. First come, first served!

24

FRIDAY 17 FEBRUARY - FULL PROGRAMME 09.15-10.15 PLENARY 2 KEYNOTE LECTURE

PLENARY HALL

09.15-10.15 PLE-2 Long term psychological and cognitive recovery after critical illness Leanne Aitken, UK

10.15-11.00 BREAK - POSTERS - EXHIBITION 11.00-12.30 PARALLEL SESSION

8 RESPIRATORY MANAGEMENT OF CRITICALLY ILL PATIENTS sponsored by Armstrong Medical Belfast

PLENARY HALL

11.00-11.30 Introducing high flow and CPAP to Liverpool Heart and Chest Hospital and its impact on Length of Stay James Greenwood, UK

11.30-12.00 Principles of sputum clearance in post-operative ICU patients and its impact on recovery Paula Agostini, UK

12.00-12.30 Promoting cough in mechanically ventilated critically ill patients Louise Rose, Canada

11.00-12.30 ORAL

PRESENTATIONS 9 ICU COMPLEX CARE ROOM 3

11.00-11.15 OP9-01 Older age, co-morbid illness and injury severity affect immediate outcome in elderly trauma patients. Dvora Kirshenbom, Israel

11.15-11.30 OP9-02 Sharing excellence on specific aspects of nursing care for patients on Extra Corporeal Life Support. Roland Burgers, The Netherlands

11.30-11.45 OP9-03 A changing care environment: the system and nursing-skill requirements set by Tele-ICU Merja Meriläinen, Finland

11.45-12.00 OP9-04 The complex care for the patient on the move Lina Bergman, Sweden

12.00-12.15 OP9-05 Nursing cares in combination of extracorporeal membrane oxygenation and continuous renal replacement therapy in critically ill patients Olga Vallès, Spain

12.15-12.30 OP9-06 Developing the role of the senior staff nurse in cardiorespiratory ICU, to undertake the role of ECMO retrieval nurse Ian Naldrett, United Kingdom

24

FRIDAY 17 FEBRUARY - FULL PROGRAMME 09.15-10.15 PLENARY 2 KEYNOTE LECTURE

PLENARY HALL

09.15-10.15 PLE-2 Long term psychological and cognitive recovery after critical illness Leanne Aitken, UK

10.15-11.00 BREAK - POSTERS - EXHIBITION 11.00-12.30 PARALLEL SESSION

8 RESPIRATORY MANAGEMENT OF CRITICALLY ILL PATIENTS sponsored by Armstrong Medical Belfast

PLENARY HALL

11.00-11.30 Introducing high flow and CPAP to Liverpool Heart and Chest Hospital and its impact on Length of Stay James Greenwood, UK

11.30-12.00 Principles of sputum clearance in post-operative ICU patients and its impact on recovery Paula Agostini, UK

12.00-12.30 Promoting cough in mechanically ventilated critically ill patients Louise Rose, Canada

11.00-12.30 ORAL

PRESENTATIONS 9 ICU COMPLEX CARE ROOM 3

11.00-11.15 OP9-01 Older age, co-morbid illness and injury severity affect immediate outcome in elderly trauma patients. Dvora Kirshenbom, Israel

11.15-11.30 OP9-02 Sharing excellence on specific aspects of nursing care for patients on Extra Corporeal Life Support. Roland Burgers, The Netherlands

11.30-11.45 OP9-03 A changing care environment: the system and nursing-skill requirements set by Tele-ICU Merja Meriläinen, Finland

11.45-12.00 OP9-04 The complex care for the patient on the move Lina Bergman, Sweden

12.00-12.15 OP9-05 Nursing cares in combination of extracorporeal membrane oxygenation and continuous renal replacement therapy in critically ill patients Olga Vallès, Spain

12.15-12.30 OP9-06 Developing the role of the senior staff nurse in cardiorespiratory ICU, to undertake the role of ECMO retrieval nurse Ian Naldrett, United Kingdom

25

Friday 17 February – continued


ICU NURSING WORKLOAD ROOM 2

11.00-11.15 OP10-01 Critical care nurses' experiences of temporary staffing in ICU Åsa Engström, Sweden

11.15-11.30 OP10-02 Adverse events related to the severity and nursing workload in Intensive Care Unit Claudia Cyrino, Portugal

11.30-11.45 OP10-03 Nursing workload required by patients admitted in Intensive Care Unit after brain or pituitary tumor surgery Lilia de Souza Nogueira, Brazil

11.45-12.00 OP10-04 The influence of the type of admission on nursing workload required by patients in the Intensive Care Unit Lilia de Souza Nogueira, Brazil

12.00-12.15 OP10-05 Validation of a model to estimate the nursing workload required by trauma victims on Intensive Care Unit discharge Karoline Silva Bonfim, Brazil

12.15-12.30 OP10-06 Quality of intensive care in relation to nurse/patient ratio and care complications Ann-Charlotte Falk, Sweden

11.00-12.30 MASTERCLASS 2 RESEARCH METHODS ROOM 1

How to write a clinical trial research protocol Bronagh Blackwood, Northern Ireland

Process evaluation Lydia Emerson, Northern Ireland

12.30-13.30 LUNCH BREAK - POSTERS - EXHIBITION 13.30-15.00 ORAL

PRESENTATIONS 11 INFECTION CONTROL PLENARY HALL

13.30-13.45 OP11-01

Healthcare-associated infections and patient safety Stijn Blot, Belgium

13.45-14.00 OP11-02 Health Care Associated Infections and Patient Safety Karin Castro Digné, Sweden

14.00-14.15 OP11-03 Continuous daily closed circle television (CCTV) is a new monitoring tool of hand hygiene healthcare workers in intensive care unit Alexander Erblat, Israel

14.15-14.30 OP11-04 Ventilator associated pneumonia nurse-directed selected prevention Alicia San Jose, Spain

14.30-14.45 OP11-05 Think infection? Think sepsis! - Revisiting sepsis awareness in the undergraduate nursing curriculum Aidín Mckinney, United Kingdom

14.45-15.00 Q&A

26



PERIOPERATIVE CARE ROOM 3

13.30-13.45 OP12-01

Emergency Chest Reopening in the Cardiac Surgery Intensive Care Unit, an operating model Simone Benedet, Italy

13.45-14.00 OP12-02 Clinical and functional changes in older individuals Post TAVI Efrat Markulesko, Israel

14.00-14.15 OP12-03 Effects of Nurse-Led Clinical Pathway in Coronary Artery Bypass Graft Surgery: More Successful Patient Outcomes Ayda Kebapçi, Turkey

14.15-14.30 OP12-04 The Effect of Progressive Relaxing Exercises After Endotracheal Extubation on Vital Signs and Anxiety Level in Open Heart Surgery Patients Ozlem Ibrahimoglu, Turkey

14.30-14.45 OP12-05 Nurses´ experiences with initiating and responding to patients´ cues and concerns in postoperative care unit - an intervention study Anne Lise Falch, Norway

14.45-15.00 OP12-06 Urinary retention - our responsibility! Observations and actions in perioperative care Hilde-Irén Liland, Norway

13.30-15.00 PARALLEL SESSION WHAT’S NEW IN CLINICAL RESEARCH ROOM 2

In this session we provide delegates with information about new Critical Care studies that are starting, ongoing or just recently completed. There will be short informative presentations with the focus on the clinical relevance and benefits of the research. Dr. Ruth Kleinpell, Dr. Marc van den Boogaard and Dr. Claire Kydonaki will be among the presenters.

13.30-15.00 WORKSHOP 2 SCREAM: STANDARDISED CRITICAL CARE

RESUSCITATION AND EMERGENCY AIRWAY MANAGEMENT

ROOM 1



Team: Gareth Morrison, Bill Hickland, Matt Jasztal, Karen Conn, Robert McMonagle, Catherine McFall, Blinnia Hughes and Christina McMahon

Can't Intubate Can't Oxygenate

A blocked tracheostomy tube

15.00-15.30 BREAK - POSTERS - EXHIBITION

27



MOBILISATION & RESTRAINT PLENARY HALL

15.30-15.45 OP13-01

Differences in perceptions, among caregivers working at the bedside, of the risks of the rehabilitation procedures Laurent Poiroux, France

15.45-16.00 OP13-02 The evaluation of 'Balance-training'; a new method in the aftercare of intensive care patients Margo van Mol, The Netherlands

16.00-16.15 OP13-03 Salient beliefs regarding physical restraint use at intensive care units: an elicitation study from the theory of planned behaviour Gemma Via-Clavero, Spain

16.15-16.30 OP13-04 Early and active mobilisation of critically ill patients in intensive care unit Gitte Frederiksen, Denmark

16.30-16.45 OP13-05 Fixation and Mobilization of the Intensive Care Patient from a completely different Perspective Christien Vrielink & Joke van Buuren, The Netherlands

16.45-17.00 OP13-06 Patients experience of in bed-cycling' in ICU Mona Ringdal, Sweden

15.30-17.00 ORAL

PRESENTATIONS 14 PSYCHOLOGICAL CARE ROOM 3

15.30-15.45 OP14-01

Association between post traumatic stress symptoms and sense of coherence in intensive care unit patients Åse Valsø, Norway

15.45-16.00 OP14-02 Shock and ignorance: Images of acute critical illness in diaries by close family of patients suffering necrotizing fasciitis Ingrid Egerod, Denmark

16.00-16.15 OP14-03 What do ICU patients rate as most important - and how is this met? Result from an empowerment questionnaire study Ingrid Wåhlin, Sweden

16.15-16.30 OP14-04 Doing it my way; Intensive Care Unit (ICU) patients' experiences of their ICU stay and recovery period Britt Sætre Hansen, Norway

16.30-16.45 OP14-05 Multiple symptoms in family caregivers of intensive care patients Hanne Birgit Alfheim, Norway

16.45-17.00 OP14-06 Using Intervention Mapping to develop a discharge protocol in the intensive care; needs assessment involving three perspectives Margo van Mol, The Netherlands

28


15.30-17.00 WORKSHOP 3 ESPNIC - CARING FOR A CHILD IN AN ADULT ICU

ROOM 2


Caring for a child in an adult ICU: differences and similarities and interactive lecture and case based workshop Lyvonne Tume, UK

15.30-17.00 WORKSHOP 4 MANUAL HYPERINFLATION

hosted by Armstrong Medical

ROOM 1

Armstrong Medical in cooperation with Frederique Paulus, The Netherlands


Blind test manual ventilation

Manual Hyperinflation, indications/contraindications and tips

Workshop on good techniques

20.00-23.30 Congress Party at Titanic Belfast


Notes:

28


15.30-17.00 WORKSHOP 3 ESPNIC - CARING FOR A CHILD IN AN ADULT ICU

ROOM 2


Caring for a child in an adult ICU: differences and similarities and interactive lecture and case based workshop Lyvonne Tume, UK

15.30-17.00 WORKSHOP 4 MANUAL HYPERINFLATION

hosted by Armstrong Medical

ROOM 1

Armstrong Medical in cooperation with Frederique Paulus, The Netherlands


Blind test manual ventilation

Manual Hyperinflation, indications/contraindications and tips

Workshop on good techniques

20.00-23.30 Congress Party at Titanic Belfast


Notes:

29

SATURDAY 18 FEBRUARY - PROGRAMME AT A GLANCE

PLENARY HALL

09.30-10.15 Plenary Session 3 Keynote Lecture

Professor Stijn Blot: Antibiotic therapy in the ICU: what nurses should know



11.00-12.00

The Global session!

EfCCNa, ESICM, WFCCN & SCCM –

hot topics affecting critical care


Humanistic Care

Workshop 5

Haemodynamic Monitoring

hosted by Edwards life Science

max. 40 pax*

Workshop 6

SCREAM max. 50 pax*

PLENARY HALL

12.00-12.30 Plenary Session 4 EfCCNa Fellows

Closing Remarks Congress Chairs

* Please collect an entrance ticket at the Registration Desk. First come, first served.

30

SATURDAY 18 FEBRUARY - FULL PROGRAMME 09.30-10.15 PLENARY 3 KEYNOTE LECTURE

PLENARY HALL

09.30-10.15 PLE-3 Antibiotic therapy in the ICU: what nurses should know Stijn Blot, Belgium

10.15-11.00 BREAK - POSTERS - EXHIBITION 11.00-12.00 PARALLEL SESSION THE GLOBAL SESSION!

EfCCNa, ESICM, WFCCN & SCCM – HOT TOPICS AFFECTING CRITICAL CARE

PLENARY HALL

Hot topics affecting critical care will be presented by the presidents of the global Critical Care societies: ESICM, WFCCN, SCCM & EfCCNa.

11.00-12.00 ORAL

PRESENTATIONS 15 HUMANISTIC CARE ROOM 3

11.00-11.15 OP15-01 Remedies for Cultural Diversity: Perception of Critical Care Nurses' in Turkey Begum Yalcin, Turkey

11.15-11.30 OP15-02 Providing Patient and Family Centered Care for the Critically-Ill Lesbian, Gay, Bisexual and Transgendered (LGBT) Patient Kristopher Jackson, U.S.A.

11.30-11.45 OP15-03 Treating civilian casualties of war from an adversary country- finding heart and soul in ICU Orly Kolpak, Israel

11.45-12.00 OP15-04 Organ donation in Montenegro Damir Pelicic, Montenegro

11.00-12.00 WORKSHOP 5

HAEMODYNAMIC MONITORING Hosted by Edwards life Science

ROOM 2


11.00-11.30 Hands on hemodynamic monitoring workshop Haleigh Watson, UK

11.30-12.00 Interactive presentation on CVP Paul van der Heiden, Switzerland

31

Saturday 18 February – continued

11.00-12.00 WORKSHOP 6

SCREAM: STANDARDISED CRITICAL CARE RESUSCITATION AND EMERGENCY AIRWAY MANAGEMENT

ROOM 1



The haemorrhagic blood loss protocol

12.00-12.30 PLENARY 4 CLOSING SESSION

PLENARY HALL

EfCCNa Fellows

Closing remarks Congress Chairs

Notes:

32

Sidhil ½ Page advertisement ZWART-WIT Notes:

A member of the Drive DeVilbiss Group of Companies

Utilising state of the art design for ease of use and flexibility, the new Activ8 range and Innov8 beds meet all current European requirements and standards for medical devices.

C

M

Y

CM

MY

CY

CMY

K

ECCC Advert - Jan 17 (print ready).pdf 1 24/01/2017 14:42

33

POSTER PRESENTATIONS

The poster number is the same as the poster board number. In the overview below the presenting authors are mentioned. For the full author details, please consult the online abstract book. All posters will be on display from Thursday 16 February 10.15 hrs. until Saturday 18 February 11.00 hrs. Presenters will be by their posters for discussion • during the morning coffee breaks on Thursday, Friday and Saturday, and • the second half of the lunch break on Thursday and Friday

01 Need for specialised critical care in the University Hospital of OULU: a point prevalence study Elina Karjula, Finland 02 The development of an enteral feeding algorithm to improve the delivery of nutrition to critically ill patients Gayle Hobson, United Kingdom 03 A nutritional algorithm for patients with acute COPD exacerbations in need of non-invasive ventilation Veronika Kongshaug Nilsen, Norway 04 The role of the extracorporeal membrane oxygenation in cardiac arrest; a review Javier Ávila Rentero, Spain 05 Spontaneous subarachnoid hemorrhage from a cerebral mycotic aneurysm: case report with nursing emphasis Mira Zool, Israel 06 Cardiovascular disease and high risk pregnancy Mali Bartal, Israel 07 Pulmonary Hypertension during Pregnancy:caring for the high risk mother in ICCU Yeudit Vaknin, Israel 08 High risk pregnancy in women with and without established cardiovascular disease Mali Bartal, Israel 09 Determination of approximate volume blood withdrawn in critical patient in the first 24 hours of admission in Intensive Care Unit Mònica Maqueda, Spain 10 Undetected injuries in severely injured patients after initial trauma care Helen Harborn, Sweden 11 Sepsis as a serious problem in nursing care Frantisek Nano, Slovak Republic

A member of the Drive DeVilbiss Group of Companies

Utilising state of the art design for ease of use and flexibility, the new Activ8 range and Innov8 beds meet all current European requirements and standards for medical devices.

C

M

Y

CM

MY

CY

CMY

K

ECCC Advert - Jan 17 (print ready).pdf 1 24/01/2017 14:42

34

12 Select Issues in the Care of Patients with Lyell's Syndrome Aurelia Sega, Poland 13 Nurse Consultant a New professional role for the Critical Care Nurse Eva Barkestad, Sweden 14 MDT quality improvement initiative to increase awareness and availability of Tracheostomy equipment following discharge from the GICU at Beaumont Hospital. Aileen Mccabe, Ireland 15 Spontaneous delivery of a healthy baby girl during veno-venous extracorporeal membrane oxygenation treatment Marjeta Zakrajšek, Slovenia 16 Nurse insertion tool Simone Benedet, Italy 17 The core team, to improve the physical and mental state of critical care patients during and after critical care admission Catharina Koper, The Netherlands 18 Family members' experiences with ICU diaries when the patient does not survive Maria Johansson, Sweden 19 Participation in follow-up after critical illness and intensive care - a way to improve the follow-up offer? Stine Irene Flinterud, Norway 20 ICU diaries: what works, for whom and in what circumstances? Carla Doherty, Northern Ireland 21 Abstract withdrawn 22 An overview of Patient Diaries for use in supporting patients' psychological recovery after discharge from the ICU Catherine Hyland, Ireland 23 Health and support to families living with a member of critical illness' - A pilot RCT study Gunilla Hollman Frisman, Sweden 24 A literature review exploring the lived experience of bereaved relatives of patients who die in the Intensive Care Unit Catherine Hyland, Ireland

35

25 End-of-life care in the intensive care unit - Let the family in and offer a follow-up visit Isabell Fridh, Sweden 26 Opening the Door: Improving Care of Dying Patients and their Families in an Intensive Coronary Care Unit Naela Aslan, Israel 27 Shared Decision Making: A case study using Family Centered Care (FCC) Nikol Bekman, Israel 28 Children as next of kin - Improving family centered care Charlotte Förars, Sweden 29 How the initial care and intensive treatment of a patient with a life-threatening condition is perceived by the patient's relatives Dragica Karadžic, Slovenia 30 Care for relatives of the dying or dead ICU patient: a quality improvement project for intensive care nurses Per Erling Bakkelund, Norway 31 Peer-preceptorship - a way to promote reflective practice Hanne Juul Mikkelsen, Denmark 32 Development of a Critical-Care Nurse Examination Lena Stevens, Sweden 33 Structured Assessment of Students in a Critical-Care Nursing program Lena Stevens, Sweden 34 ICU physician-nurse shared clinical decision making: Fluid bolus administration Freda Dekeyser Ganz, Israel 35 CCNs experiences of nursing trauma patients Linda Sandström, Sweden 36 The helicopter as a caring context: trauma patients' experiences Linda Sandström, Sweden 37 Nurse Work Environments: Perspectives from Canada and the United Kingdom Sandra Goldsworthy, Canada 38 Perception of Consciousness in Non-Communicative Patients by Nurses and Nursing Assistants in a Neurological Intensive Care Unit Sebastien Labat, France

36

39 How do patients experience the ICU after gastrointestinal surgery and which consequences can be derived for the management? Anneliese Raab, Austria 40 Nursing Interventions before, during and after Transcatheter Mitral Valve Repair (TMVR): New hope for patients with Degenerative Mitral Regurgitation (DMR) Siham Sheblemasarwa, Israel 41 The Role of Rapid Response System Teams in End-of-Life Care Decision-making: a systematic review Laura Creighton, United Kingdom 42 Awareness of citizens of Montenegro on organ donation Damir Pelicic, Montenegro 43 Organ Donation in the Intensive Care Unit (ICU) Breda Doyle, Ireland 44 Ethical rounds - a possibility for the ICU staff to identify and discuss ethical issues regarding the critical care patient Åsa Hällström, Sweden 45 Delirium implementation Susanne Nielsen, Denmark 46 The acronym G.H.O.S.T.M.I.N.D as a prevention tool in the diagnosis of delirium Anne Sanderson, United Kingdom 47 Goal Directed Sedation (GDS) for improving quality of care Shelly Ashkenazy, Israel 48 Sleep and sedation practices of Intensive Care nurses: a United Kingdom survey Jennifer Mcgaughey, United Kingdom 49 Pain in the emergency department of a German hospital - incidence, intensity and localization Patrick Ristau, Germany 5 Group discussion on nurses in acute confusional Intensive Care Unit Miguel Cachón Pérez, Spain 51 Implementing a pain assessment Tool CPOT for non-self-reporting patients in two intensive care units Karin Kaasby, Denmark 52 Elderly patients with sedatives and hypnotics in Intensive Care Units Elaine Oliveira, Brazil

37

53 How to implement early mobilisation in ICU? Louise Malmgren, Sweden 54 Training and active mobilization in the ICU Lone Bredvig, Denmark 55 Early Mobilization in Intensiv Therapy (MIT-project) Anne Langvad, Denmark 56 Patient mobilization techniques for nurses Diana Solms, Norway 57 Patient-oriented process optimization in a central emergency department Patrick Ristau, Germany 58 Implementing double check process of administration of high risk medications in general ICU Levana Jakobson, Israel 59 What is hot about CPR? Yardena Drori, Israel 60 Establishing a National Database for Medical Errors Dana Arad, Israel 61 Severity and workload of patients eligible for admission in intensive care unit Claudia Cyrino, Portugal 62 Efficacy and Compliance with Early Warning Scores - the results of 2 systematic reviews Nicola Credland, United Kingdom 63 »Blame and punishment« in emergency nursing care Lucija Rojko, Slovenia 64 Content and cultural validation of an IHI ICU Adverse Event Trigger Tool for Finnish intensive care Heljä Lundgrén-Laine, Finland 65 Enhanced Recovery Program (ERP) - a step towards safer care Hanna Nordin, Sweden 66 Nursing workload in Brazilian Intensive Care Units in 2012 and 2016 Elaine Oliveira, Brazil

38

67 Development of a clinical intervention project concerning ICU patient room environment: an application of Medical Research Council's (MRC) framework Berit Lindahl, Sweden 68 What does empowerment mean in a critical care context? Ingrid Wåhlin, Sweden 69 A mixed-methods approach for conducting a process evaluation of trials of complex interventions in the critical care setting Linda Emerson, Northern Ireland 70 The relevance of realist reviews to critical care nursing Carla Doherty, Northern Ireland 71 Psychometric assessment of the Polish version of the behavioral pain scale in intubated critically ill patients Aleksandra Gutysz-Wojnicka, Poland 72 Global self-esteem and socio-demographic variables as predictors of burnout syndrome among Polish nurses Ewa Kupcewicz, Poland 73 Positive orientation and the perceived quality of interpersonal relationships in the work of Polish nurses Ewa Kupcewicz, Poland Notes:

39

Notes:

40

Notes:

7th efccna congress 2017 6 efccna congress 2015 horizons of critical care nursing in europe ......

Documents